These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17097782)

  • 1. Multiple myeloma: a multifactorial problem for the hand surgeon as a patient.
    Al-Qattan MM
    J Hand Surg Eur Vol; 2007 Feb; 32(1):110-1. PubMed ID: 17097782
    [No Abstract]   [Full Text] [Related]  

  • 2. [Allogeneic bone marrow transplantation in multiple myeloma].
    Bandini G; Rosti G; Cavo M; Albertazzi L; Rizzi S; Motta MR; Gobbi M; Tassi C; Tazzari PL; Miggiano C
    Haematologica; 1989 Oct; 74(5 Suppl):463-72. PubMed ID: 2512229
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of multiple myeloma.
    Richards JD; Singer CR; Tobias JS
    Br J Hosp Med; 1987 May; 37(5):437, 440-2. PubMed ID: 2437986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple myeloma: past, present and future].
    Zulian GB
    Rev Med Suisse Romande; 1989 Nov; 109(11):939-45. PubMed ID: 2688027
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloma bone disease: pathogenesis and treatment.
    Roodman GD;
    Oncology (Williston Park); 2005 Jul; 19(8):983-4, 986. PubMed ID: 16131042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple myeloma].
    Almazov VA; Afanasév BV; Podoltseva ZI
    Klin Med (Mosk); 1993; 71(2):5-10. PubMed ID: 8046926
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
    van Rhee F
    Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circulatory failure and the methods for its correction in multiple myeloma].
    Bessmel'tsev SS; Abdulkadyrov KM
    Ter Arkh; 1992; 64(7):62-6. PubMed ID: 1440372
    [No Abstract]   [Full Text] [Related]  

  • 11. Complete remission of multiple myeloma after autoimmune hemolytic anemia: possible association with interferon-alpha.
    Gesundheit B; Zelig O; Shapira MY; Ackerstein A; Avgil M; Or R
    Am J Hematol; 2007 Jun; 82(6):489-92. PubMed ID: 17236186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment for multiple myeloma: current status and future strategy in Japan].
    Iida S
    Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
    [No Abstract]   [Full Text] [Related]  

  • 13. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
    Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
    Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple myeloma].
    Peest D
    Ther Umsch; 1996 Feb; 53(2):147-51. PubMed ID: 8629265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma.
    El-Cheikh J; Michallet M; Nagler A; de Lavallade H; Nicolini FE; Shimoni A; Faucher C; Sobh M; Revesz D; Hardan I; Fürst S; Blaise D; Mohty M
    Haematologica; 2008 Mar; 93(3):455-8. PubMed ID: 18287132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma.
    Mehta GR; Suhail F; Haddad RY; Zalzaleh G; Lerma EV
    Dis Mon; 2014 Oct; 60(10):483-8. PubMed ID: 25288376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
    Shimizu K;
    Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of multiple myeloma: present and future].
    Tura S
    G Clin Med; 1986 Dec; 67(5-6):261-4, 266-7. PubMed ID: 3301488
    [No Abstract]   [Full Text] [Related]  

  • 19. Yellow fever vaccine: a successful vaccination of an immunocompromised patient.
    Gowda R; Cartwright K; Bremner JA; Green ST
    Eur J Haematol; 2004 Apr; 72(4):299-301. PubMed ID: 15089771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
    Mellqvist UH; Lenhoff S; Johnsen HE; Hjorth M; Holmberg E; Juliusson G; Tangen JM; Westin J;
    Cancer; 2008 Jan; 112(1):129-35. PubMed ID: 17973267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.